Medincell SA
PAR:MEDCL
Income Statement
Earnings Waterfall
Medincell SA
Income Statement
Medincell SA
| Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
2
|
2
|
2
|
4
|
4
|
2
|
2
|
4
|
4
|
3
|
5
|
5
|
5
|
5
|
|
| Revenue |
1
N/A
|
3
+82%
|
3
+9%
|
2
-25%
|
8
+284%
|
9
+5%
|
4
-52%
|
9
+108%
|
10
+16%
|
11
+10%
|
9
-17%
|
11
+18%
|
25
+138%
|
28
+12%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(2)
|
(1)
|
(1)
|
0
|
|
| Gross Profit |
0
N/A
|
1
+205%
|
2
+43%
|
1
-51%
|
7
+632%
|
7
+6%
|
3
-64%
|
7
+168%
|
6
-7%
|
7
+1%
|
7
+3%
|
10
+44%
|
24
+148%
|
0
N/A
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(16)
|
(18)
|
(21)
|
(20)
|
(22)
|
(26)
|
(26)
|
(31)
|
(31)
|
(28)
|
(28)
|
(29)
|
(35)
|
(38)
|
|
| Selling, General & Administrative |
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(8)
|
(8)
|
(9)
|
(9)
|
(11)
|
(11)
|
(12)
|
(14)
|
(15)
|
|
| Research & Development |
(10)
|
(13)
|
(15)
|
(15)
|
(17)
|
(21)
|
(21)
|
(24)
|
(23)
|
(19)
|
(18)
|
(18)
|
(22)
|
(25)
|
|
| Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Other Operating Expenses |
3
|
4
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
3
|
3
|
3
|
2
|
4
|
|
| Operating Income |
(16)
N/A
|
(17)
-9%
|
(19)
-14%
|
(19)
0%
|
(16)
+20%
|
(19)
-20%
|
(24)
-28%
|
(24)
-2%
|
(24)
+1%
|
(21)
+11%
|
(21)
+2%
|
(20)
+6%
|
(11)
+45%
|
(10)
+8%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
(4)
|
(2)
|
(2)
|
(4)
|
(3)
|
(1)
|
(1)
|
(2)
|
(8)
|
(5)
|
(4)
|
(12)
|
(7)
|
(10)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
|
| Total Other Income |
(1)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
|
| Pre-Tax Income |
(20)
N/A
|
(19)
+5%
|
(21)
-14%
|
(23)
-8%
|
(19)
+18%
|
(20)
-5%
|
(25)
-24%
|
(27)
-8%
|
(32)
-19%
|
(26)
+17%
|
(25)
+6%
|
(31)
-26%
|
(18)
+42%
|
(20)
-9%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
(0)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(20)
|
(19)
|
(24)
|
(26)
|
(19)
|
(20)
|
(25)
|
(27)
|
(32)
|
(26)
|
(25)
|
(32)
|
(18)
|
(20)
|
|
| Income to Minority Interest |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(20)
N/A
|
(19)
+4%
|
(24)
-27%
|
(26)
-7%
|
(19)
+26%
|
(20)
-5%
|
(25)
-24%
|
(27)
-8%
|
(32)
-19%
|
(26)
+17%
|
(25)
+5%
|
(32)
-26%
|
(18)
+42%
|
(20)
-8%
|
|
| EPS (Diluted) |
-1.14
N/A
|
-0.94
+18%
|
-1.19
-27%
|
-1.2
-1%
|
-0.86
+28%
|
-0.8
+7%
|
-1
-25%
|
-1.07
-7%
|
-1.27
-19%
|
-0.94
+26%
|
-0.88
+6%
|
-1.08
-23%
|
-0.62
+43%
|
-0.61
+2%
|
|